Accelerate Naïve & Engineered Exosome Development through Advanced Purification, Biology & Production Consistency for Translation to Clinical Success & GMP Compliant Scalability

The Industry-Led Forum to Bridge Exosome
Science & Drug Development for Commercialization

Now more than ever, exosome and extracellular vesicles (EV) therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments. Join us at the 6th Exosome-Based Therapeutics Development Summit in September to delve into groundbreaking advancements, access exclusive clinical data, and forge pivotal partnerships to define the future of exosome drug development.

Spanning the complete development cycle of exosome therapeutics from discovery through IND filing, our summit uniquely integrates cutting-edge research with practical commercialization strategies. It stands as the sole industry meeting that bridges the gap between science and business, propelling clinical advancements.

Don't miss the chance to connect with over 130 leading experts across large pharma, biotechs, academics, gain invaluable insights, and place your work at the forefront of pharmaceutical innovation. Join us this September and advance your exosome and EV candidate with meaningful partnerships and commercialization in 2024.

World-Class Speaker Faculty Includes:

Previously Attending Companies Include:

homepage banners (20)

Our Partners

lonza logo
biological dynamics logo
newlogo jpeg (002)
NIS Color Logo with Tagline
Other Events in the Exosome Series:
HW231206 Exosome Based Characterization & Analytical Development Summit logo FINAL W (2)